| Source: |
| Type: |
| COX‑1 is traditionally considered a constitutively expressed enzyme involved in “housekeeping” functions, while COX‑2 is more frequently studied in relation to cancer. • The prognostic impact of COX‑1 may vary based on cancer subtype, stage, and interplay with other inflammatory mediators (e.g., COX‑2). • Many studies assess combined cyclooxygenase profiles (COX‑1/COX‑2) rather than COX‑1 alone. |
| Normal Healthy |
| 5413- | ASA, | Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin |
| - | Trial, | Nor, | NA |
| 5400- | ASA, | Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention |
| - | Review, | Nor, | NA |
| 5401- | ASA, | Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation |
| - | Review, | Nor, | NA |
| 5757- | CAPE, | Caffeic acid phenethyl ester (CAPE): pharmacodynamics and potential for therapeutic application |
| - | Review, | Nor, | NA |
| 2466- | CUR, | Regulatory Effects of Curcumin on Platelets: An Update and Future Directions |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:998 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid